BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25427576)

  • 1. Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma.
    Keskin S; Keskin Z; Taskapu HH; Kalkan H; Kaynar M; Poyraz N; Toy H
    BMC Urol; 2014 Nov; 14():95. PubMed ID: 25427576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Chang X; Zhang F; Liu T; Wang W; Guo H
    Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.
    de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T
    J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of hematologic parameters on the prognosis of patients with metastatic renal cell carcinoma.
    Dirican A; Kucukzeybek Y; Somali I; Erten C; Demir L; Can A; Bahriye Payzin K; Vedat Bayoglu I; Akyol M; Koseoglu M; Alacacioglu A; Oktay Tarhan M
    J BUON; 2013; 18(2):413-9. PubMed ID: 23818354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram.
    Gu L; Ma X; Li H; Chen L; Xie Y; Zhao C; Luo G; Zhang X
    Sci Rep; 2016 Mar; 6():23846. PubMed ID: 27035802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
    Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
    BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.
    Mano R; Flynn J; Blum KA; Silagy AW; DiNatale RG; Marcon J; Wang A; Sanchez A; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
    Urol Oncol; 2019 Dec; 37(12):916-923. PubMed ID: 31590969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
    Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
    BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emphasis of neutrophil-to-lymphocyte ratio in non-metastatic renal cell carcinoma.
    Ceylan C; Camtosun A; Doluoglu OG; Tasdemir S; Keles I; Aglamis E; Tatar CA
    Urologia; 2014; 81(1):51-6. PubMed ID: 24474536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging.
    Elghiaty A; Kim J; Jang WS; Park JS; Heo JE; Rha KH; Choi YD; Ham WS
    Medicine (Baltimore); 2018 Nov; 97(48):e13433. PubMed ID: 30508956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of ultrasound-indeterminate renal multilocular cystic masses by using neutrophil-lymphocyte ratio and computed tomography.
    Wang H; Gu L; Jia R; Zeng J; Liu X; Zhang D; Wu Y; Luo G; Zhang X
    Urol Oncol; 2017 Jan; 35(1):35.e7-35.e14. PubMed ID: 27671994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma.
    Ohno Y; Nakashima J; Ohori M; Hatano T; Tachibana M
    J Urol; 2010 Sep; 184(3):873-8. PubMed ID: 20643463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model.
    Chrom P; Stec R; Bodnar L; Szczylik C
    Cancer Res Treat; 2018 Jan; 50(1):103-110. PubMed ID: 28253564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma.
    Ohno Y; Nakashima J; Ohori M; Gondo T; Hatano T; Tachibana M
    J Urol; 2012 Feb; 187(2):411-7. PubMed ID: 22177153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
    Kuzman JA; Stenehjem DD; Merriman J; Agarwal AM; Patel SB; Hahn AW; Alex A; Albertson D; Gill DM; Agarwal N
    BMC Urol; 2017 Jan; 17(1):1. PubMed ID: 28056941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer.
    Sidana A; Kadakia M; Friend JC; Krane LS; Su D; Merino MJ; Srinivasan R
    Urol Oncol; 2017 Mar; 35(3):114.e9-114.e14. PubMed ID: 27914873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma.
    Yuk HD; Kang M; Hwang EC; Park JY; Jeong CW; Song C; Seo SI; Byun SS; Kwak C; Hong SH; Chung J; Lee H;
    Investig Clin Urol; 2020 Sep; 61(5):475-481. PubMed ID: 32734724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?
    Gorgel SN; Ozer K; Kose O; Dindar AS
    Int Braz J Urol; 2018; 44(3):461-466. PubMed ID: 29211406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.